6 unchanged sentences
(incorporated by reference to Exhibit 3.2 to the Registrant’s Current Report on Form 8-K, filed with the SEC on October 24, 2022).
+Added: 10.1* Lease Agreement, dated as of November 22, 2021, between NW Cambridge Property Owner, LLC and the Registrant
+Added: 10.2* Sixth Amendment to License Agreement, dated April 5, 2022, between Prime Medicine, Inc.
+Added: and MIL 21E, LLC
+Added: 10.3* Ninth Amendment to License Agreement, dated March 17, 2023, between Prime Medicine, Inc.
+Added: and MIL 21E, LLC
+Added: 10.4* Tenth Amendment to License Agreement, dated April 14, 2023, between Prime Medicine, Inc.
+Added: and MIL 21E, LLC
+Added: 10.5* Eleventh Amendment to License Agreement, dated May 4, 2023, between Prime Medicine, Inc.
+Added: and MIL 21E, LLC
31.1* Certification of Principal Executive Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
18 unchanged sentences
Prime Medicine, Inc.
−Removed: May 11, 2023 By:
+Added: August 07, 2023 By:
/s/ Keith Gottesdiener
1 unchanged sentence
President and Chief Executive Officer
−Removed: May 11, 2023 By:
+Added: (Principal Executive Officer)
+Added: August 07, 2023 By:
/s/ Carman Alenson
Carman Alenson
−Removed: Interim Chief Financial Officer and Chief Accounting Officer (Principal Accounting Officer and Principal Financial Officer)
+Added: Interim Chief Financial Officer and Chief Accounting Officer
+Added: (Principal Accounting Officer and Principal Financial Officer)
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.